Baudax Bio, Inc. announced that it has entered into a share purchase agreement for the gross proceeds of $50 million on August 23, 2023. The transaction will include participation from new investor, Alumni Capital LP.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.008 USD | +23.08% | +6.67% | -63.64% |
06-17 | First Motion for Exclusivity Period Extension Filed by Baudax Bio, Inc. | CI |
02-22 | Baudax Bio, Inc. Filed for Bankruptcy | CI |
1st Jan change | Capi. | |
---|---|---|
-63.64% | 341K | |
+38.36% | 52.5B | |
+36.73% | 39.31B | |
-8.63% | 39.01B | |
+25.46% | 28.2B | |
-11.17% | 26.57B | |
+11.44% | 26.2B | |
+45.09% | 14.15B | |
+32.93% | 12.62B | |
-5.30% | 11.74B |
- Stock Market
- Equities
- BXRXQ Stock
- News Baudax Bio, Inc.
- Baudax Bio, Inc. announced that it expects to receive $50 million in funding from Alumni Capital LP